转换试验用于评估治疗使用和多变量临床结果之间的潜在非线性关联
Boyu Ren1, Stuart R Lipsitz2, Garrett M Fitzmaurice1
1McLean Hospital.
Multivariate behavioral research
|June 28, 2023
概括
本研究引入了用于分析心理测量研究中结果和共变量之间的复杂关系的变换测试. 这些新的方法在标准测试失败时提高了统计准确性,特别是在混合效应模型中.
科学领域:
- 统计 统计 统计 统计
- 心理测量 心理测量 心理测量
- 生物统计学 生物统计学
背景情况:
- 结果和共变量之间的复杂关系往往会在心理测量应用中挑战简单的参数模型.
- 处罚线提供灵活的非线性建模,但需要在线性混合效应模型 (LMM) 中进行适当的统计测试.
研究的目的:
- 在分析处罚分线时解决LMM中方差元件的标准统计测试的局限性.
- 提议和评估新型变量测试,以检测定量共变量对LMMs中的结果的影响.
主要方法:
- 作为LMMs来处理多变量结果,表示处罚分线.
- 为概率比测试统计制定三种变换测试 (共变量变换,余量变换).
- 将拟议测试与使用I型错误和功率模拟的标准参数测试进行比较.
主要成果:
- 拟议的排列试验在零假设下保持了准确的I型错误率.
- 模拟表明,与多个结果的联合模型的传统方法相比,排列试验具有竞争力.
结论:
- 变试验为在LMM中进行处罚splines的假设测试提供了强大的替代方案,特别是在违反了非对称假设时.
- 这些方法对于分析心理测量和临床试验数据中复杂的共同变量-结果关系是有价值的.
相关概念视频
McNemar's Test
317
McNemar's Test is a nonparametric statistical test used to determine if there is a significant difference in proportions between two related groups when the outcome is binary (e.g., yes/no, success/failure). It is beneficial when we have paired data, such as pre-test/post-test designs, where the same subjects are measured under two different conditions. The test is named after the statistician Quinn McNemar, who introduced it in 1947. It is commonly used in situations where subjects are...
317
Sign Test for Matched Pairs
169
The sign test for matched pairs offers a robust method for comparing two paired samples, often for the effects of an intervention in one of them. This method is very useful in situations where the underlying distribution of the data is unknown. The test compares two related samples—often pre- and post-treatment measurements on the same subjects—to determine if there are significant differences in their median values.
To conduct the sign test, we first calculate the differences in...
To conduct the sign test, we first calculate the differences in...
169
Comparing the Survival Analysis of Two or More Groups
228
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
228
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
The Mantel-Cox Log-Rank Test
441
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
441
Hazard Ratio
166
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
166


